Insider Transactions last 24 months for Genelux Corporation  -  NSDQ: GNLX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Smalling RalphHead of Regulatory09/01/2025AADirectCOM10,000$0.00$0.0070,990
Cappello JosephChief Technical Officer08/27/2025AADirectCOM107,500$0.00$0.00159,766
Smalling RalphHead of Regulatory08/27/2025AADirectCOM26,230$0.00$0.0060,990
Yu YongSVP, Clinical Development08/27/2025AADirectCOM101,480$0.00$0.00150,036
Zindrick ThomasPresident and CEO08/27/2025AADirectCOM361,200$0.00$0.00554,161
Thomas JohnDirector08/27/2025AADirectCOM22,283$0.00$0.00502,784
Mirabelli MaryDirector08/27/2025AADirectCOM22,283$0.00$0.0073,284
Smither John WDirector08/27/2025AADirectCOM22,283$0.00$0.0074,994
Tyree James LDirector08/27/2025AADirectCOM22,283$0.00$0.0068,074
Thomas JohnDirector06/06/2025DGDirectCOM25,000$0.00$0.00480,501
Smalling RalphHead of Regulatory05/12/2025DSDirectCOM1,259$2.92$3,676.2834,760
Cappello JosephVP, Pharmaceutical Development05/12/2025DSDirectCOM4,737$2.92$13,832.0452,266
Yu YongVP, Clinical Trial Operations05/12/2025DSDirectCOM5,579$2.92$16,290.6847,640
Zindrick ThomasPresident and CEO05/12/2025DSDirectCOM10,764$2.92$31,430.88191,447
Ryder SeanGeneral Counsel05/12/2025DSDirectCOM4,475$2.92$13,067.0047,621
Zindrick ThomasPresident and CEO03/14/2025AADirectCOM30,339$0.00$0.00202,211
Ryder SeanGeneral Counsel03/14/2025AADirectCOM10,708$0.00$0.0052,096
Yu YongVP, Clinical Trial Operations03/14/2025AADirectCOM13,350$0.00$0.0053,219
Cappello JosephVP, Pharmaceutical Development03/14/2025AADirectCOM13,350$0.00$0.0057,003
Smalling RalphHead of Regulatory03/14/2025AADirectCOM4,172$0.00$0.0036,019
Tyree James LDirector12/30/2024DSDirectCOM3,460$2.46$8,511.6045,791
Zindrick ThomasPresident and CEO12/18/2024AADirectCOM134,500$0.00$0.00171,872
Zak Lourie S.Chief Financial Officer12/18/2024AADirectCOM41,650$0.00$0.0082,452
Cappello JosephVP, Pharmaceutical Development12/18/2024AADirectCOM29,000$0.00$0.0043,653
Yu YongVP, Clinical Trial Operations12/18/2024AADirectCOM29,000$0.00$0.0039,869
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel